Scarica l'app Stockscreener
30.49
2.15%
-0.67
Dopo l'orario di chiusura:
30.49
Precedente Chiudi:
$31.16
Aprire:
$31.03
Volume 24 ore:
902.91K
Relative Volume:
1.62
Capitalizzazione di mercato:
$1.44B
Reddito:
$1.08B
Utile/perdita netta:
$-20.76M
Rapporto P/E:
-66.28
EPS:
-0.46
Flusso di cassa netto:
$151.63M
1 W Prestazione:
-1.13%
1M Prestazione:
-6.73%
6M Prestazione:
-38.78%
1 anno Prestazione:
+1.19%
Intervallo 1D:
$30.36
$31.03
Intervallo di 1 settimana:
$30.36
$32.18
Portata 52W:
$25.12
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Nome
Omnicell Inc
Settore
Industria
Telefono
(877) 415-9990
Indirizzo
4220 NORTH FREEWAY, FORT WORTH
Confronta OMCL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
30.49 | 1.44B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
236.99 | 36.73B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
59.39 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
54.07 | 9.30B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
91.42 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
40.98 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-31 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-02 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Iniziato | Barclays | Underweight |
| 2023-11-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-11-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Reiterato | Wells Fargo | Underweight |
| 2023-08-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Iniziato | BofA Securities | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-12-06 | Ripresa | Wells Fargo | Overweight |
| 2021-06-09 | Iniziato | JP Morgan | Neutral |
| 2021-05-24 | Iniziato | BTIG Research | Buy |
| 2021-02-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Iniziato | Berenberg | Buy |
| 2020-12-03 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-02-07 | Reiterato | Dougherty & Company | Buy |
| 2019-11-21 | Reiterato | Dougherty & Company | Buy |
| 2019-07-26 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2019-03-07 | Reiterato | Dougherty & Company | Buy |
| 2018-06-29 | Ripresa | The Benchmark Company | Buy |
| 2017-09-05 | Reiterato | The Benchmark Company | Buy |
| 2017-07-28 | Reiterato | Dougherty & Company | Buy |
| 2017-04-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Iniziato | Dougherty & Company | Buy |
| 2016-12-06 | Reiterato | The Benchmark Company | Buy |
| 2016-07-07 | Reiterato | FBR Capital | Outperform |
| 2016-03-21 | Reiterato | Topeka Capital Markets | Buy |
| 2016-01-07 | Iniziato | The Benchmark Company | Buy |
| 2015-11-16 | Reiterato | Topeka Capital Markets | Buy |
| 2015-10-30 | Reiterato | FBR Capital | Outperform |
| 2015-09-28 | Aggiornamento | Sidoti | Neutral → Buy |
| 2015-07-31 | Reiterato | Topeka Capital Markets | Buy |
Mostra tutto
Omnicell Inc Borsa (OMCL) Ultime notizie
Omnicell (OMCL) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
Multifunctional Intravenous Drug Dispensing Robot Market - openPR.com
Central Fill Pharmacy Automation Market Is Booming So - openPR.com
Central Fill Pharmacy Automation Market Set to Witness - openPR.com
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term - Yahoo Finance
Is The Market Rewarding Omnicell, Inc. (NASDAQ:OMCL) With A Negative Sentiment As A Result Of Its Mixed Fundamentals? - simplywall.st
Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks - The Globe and Mail
1 of Wall Street’s Favorite Stock to Target This Week and 2 to Keep Off Your Radar - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
Is it Apt to Retain Omnicell Stock in Your Portfolio Now? - Nasdaq
Investors in Omnicell (NASDAQ:OMCL) have unfortunately lost 75% over the last three years - Yahoo Finance
Future-Proofing Growth of Smart Pharmacy Dispensing System - openPR.com
Wells Fargo Adjusts Omnicell (OMCL) Price Target Amid Cost Concerns | OMCL Stock News - GuruFocus
Global Preventive Healthcare Technologies And Services Market - openPR.com
Pharmacy Automation Market Is Booming So Rapidly 2025-2032 - openPR.com
Lobbying Update: $50,000 of OMNICELL lobbying was just disclosed - Nasdaq
Pharmacy Automation Systems Market May Set New Growth Story | McKesson, Omnicell, Baxter International - openPR.com
Omnicell to Release First Quarter 2025 Financial Results on May 6, 2025 | OMCL Stock News - GuruFocus
Omnicell to Release First Quarter 2025 Financial Results on May 6, 2025 - BioSpace
Pharmacy Automation System Market is Expected to reach US$ 11.21 - openPR.com
Omnicell, Royalty Pharma, EXL, IMAX, and OPENLANE Stocks Trade Down, What You Need To Know - Yahoo Finance
Here's Why Omnicell (OMCL) is a Strong Value Stock - Yahoo Finance
Omnicell (OMCL): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Omnicell (OMCL): Buy, Sell, Or Hold Post Q4 Earnings? - Barchart.com
Omnicell (NASDAQ:OMCL) Seems To Use Debt Rather Sparingly - simplywall.st
Central Fill Pharmacy Automation Market to Witness Massive - openPR.com
Pharmacy Automation Market to Witness Remarkable Growth with - openPR.com
Consolidation at Omnicell - Pharmacy Magazine
India Pharmacy Automation Market Competition, Forecast & Opportunities Report 2025 Featuring Becton Dickinson, Omnicell, Baxter International, Cerner, and TouchPoint - GlobeNewswire
Omnicell Names Veteran Surgical Robotics Exec as Its New CTO - Dallas Innovates
Omnicell Appoints New CTO to Drive Technological Innovation - Zenopa
Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer - EnterpriseTalk
Omnicell Inc Azioni (OMCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.24%
1.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):